Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
3.850
-0.150 (-3.75%)
Jul 22, 2024, 10:01 AM EDT - Market open
Elutia Employees
Elutia had 54 employees as of December 31, 2023. The number of employees decreased by 110 or -67.07% compared to the previous year.
Employees
54
Change (1Y)
-110
Growth (1Y)
-67.07%
Revenue / Employee
$536,889
Profits / Employee
-$882,889
Market Cap
104.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Augmedix | 1,430 |
| Karyopharm Therapeutics | 325 |
| I-Mab | 220 |
| Adagene | 174 |
| BrainsWay | 134 |
| Journey Medical | 41 |
| Regulus Therapeutics | 30 |
| Telomir Pharmaceuticals | 9 |
ELUT News
- 10 days ago - Elutia to Present at the Emerging Growth Conference on Thursday, July 18 - GlobeNewsWire
- 5 weeks ago - Elutia Announces $13.26 Million Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators - GlobeNewsWire
- 3 months ago - Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1 - GlobeNewsWire
- 4 months ago - Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024 - GlobeNewsWire
- 5 months ago - Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024 - GlobeNewsWire
- 6 months ago - Elutia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 8 months ago - Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results - GlobeNewsWire